Cosaco GmbH – Trademark Portfolio
Entity Type: 16
Cosaco GmbH holds 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 8 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 5 Nice Classification classes. Currently, 7 trademarks are registered. Notable registered marks include K, COSACO, KOCIDE, KUPFEED, and CUPROZIN.
Singapurstrasse 1
20457 Hamburg
Showing of trademarks Trademarks
Trademark Classifications
Cosaco GmbH's trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Raw and unprocessed agricultural, aquacultural, horticultural and forestry products
Frequently Asked Questions
How many trademarks does Cosaco GmbH have?
Cosaco GmbH has 9 U.S. trademarks filed with the USPTO. Of these, 7 registered, 1 abandoned.
What trademark classes does Cosaco GmbH file in?
Cosaco GmbH files trademarks across 5 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 1 (Chemicals), Class 3 (Cosmetics & Cleaning), Class 31 (Natural Agricultural Products), Class 2 (Paints). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Cosaco GmbH's most well-known trademarks?
Cosaco GmbH's registered trademark portfolio includes well-known marks such as K, COSACO, KOCIDE, KUPFEED, and CUPROZIN. These are among 7 currently registered trademarks in the portfolio.
What is Cosaco GmbH's trademark registration success rate?
Cosaco GmbH has a 88% trademark registration rate, with 7 out of 8 resolved applications resulting in successful registration. Currently, 0 applications are pending review.